Cargando…

SAT-485 Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series

Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series Introduction: Thyroid dysfunction is reported in 5 - 9.5 % of patients treated with Pembrolizumab, one of the PD-1 immune checkpoint inhibitors. However, the underlying mechanism of Pembrolizumab-induced thyroid disord...

Descripción completa

Detalles Bibliográficos
Autores principales: Atalay, Hande, Mon, Sann Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207765/
http://dx.doi.org/10.1210/jendso/bvaa046.155